$301 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 53 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 16.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Buy | HORIZON THERAPEUTICS PUB LTD | $23,992,000 | +105.7% | 434,000 | +10.2% | 7.98% | +50.0% |
| BMRN | Buy | Biomarin Pharmaceutical Inc | $22,675,000 | +58.1% | 185,584 | +9.3% | 7.54% | +15.3% |
| GILD | Buy | Gilead Sciences Inc | $22,616,000 | +27.6% | 303,284 | +27.8% | 7.52% | -6.9% |
| VRTX | Sell | Vertex Pharmaceuticals Inc | $18,486,000 | -0.2% | 64,822 | -16.7% | 6.14% | -27.2% |
| IMMU | Buy | IMMUNOMEDICS INC | $15,335,000 | +1480.9% | 448,000 | +522.2% | 5.10% | +1053.2% |
| PTCT | Buy | PTC Therapuetics COM | $15,135,000 | +26.4% | 299,000 | +11.2% | 5.03% | -7.8% |
| ACAD | Sell | ACADIA PHARMACEUTICALS INC | $14,698,000 | +3.3% | 305,000 | -9.5% | 4.89% | -24.7% |
| BIIB | Buy | Biogen Inc | $13,326,000 | -7.8% | 51,200 | +12.0% | 4.43% | -32.8% |
| NBIX | Sell | Neurocrine Biosciences Inc | $13,278,000 | +43.0% | 105,800 | -1.4% | 4.41% | +4.3% |
| AMGN | Sell | Amgen Inc | $12,042,000 | -10.0% | 52,000 | -21.2% | 4.00% | -34.4% |
| CCXI | Buy | CHEMOCENTRYX INC | $10,465,000 | +37.2% | 191,600 | +0.8% | 3.48% | +0.0% |
| EXEL | Buy | Exelixis Inc | $10,286,000 | +479.2% | 452,534 | +337.1% | 3.42% | +322.1% |
| ALXN | Buy | Alexion Pharmaceuticals Inc | $9,814,000 | +48.4% | 88,241 | +19.8% | 3.26% | +8.2% |
| SGEN | Sell | Seattle Genetics Inc | $9,123,000 | +39.1% | 55,500 | -2.5% | 3.03% | +1.5% |
| INCY | Sell | Incyte Corp | $7,993,000 | +9.7% | 78,000 | -21.6% | 2.66% | -20.0% |
| HALO | Halozyme Therapeutics Inc | $7,940,000 | +43.6% | 307,633 | 0.0% | 2.64% | +4.7% | |
| REGN | New | Regeneron Pharmaceuticals | $7,020,000 | – | 11,500 | +100.0% | 2.33% | – |
| MYOK | Buy | Myokardia INC | $6,372,000 | +757.6% | 65,859 | +315.3% | 2.12% | +524.8% |
| ZGNX | Sell | Zogenix Inc | $6,172,000 | -11.3% | 236,832 | -16.0% | 2.05% | -35.3% |
| ALNY | Buy | Alnylam Pharmaceuticals Inc | $5,370,000 | +121.4% | 36,300 | +62.8% | 1.78% | +61.5% |
| MRTX | MIRATI THERAPEUTICS INC | $5,032,000 | +49.1% | 43,900 | 0.0% | 1.67% | +8.8% | |
| SRPT | Sell | Sarepta Therapeutics Inc | $3,499,000 | +27.5% | 21,500 | -23.5% | 1.16% | -7.0% |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $3,119,000 | – | 45,000 | +100.0% | 1.04% | – |
| IONS | Sell | Ionis Pharmaceuticals Inc | $2,363,000 | -7.1% | 39,781 | -26.0% | 0.78% | -32.3% |
| ENTA | ENANTA PHARMACEUTICALS INC | $2,280,000 | -4.4% | 46,500 | 0.0% | 0.76% | -30.3% | |
| KALV | Sell | Kalvista Pharmaceuticals Inc | $2,246,000 | +29.8% | 177,433 | -22.0% | 0.75% | -5.3% |
| TPTX | TURNING POINT THERAPEUTICS I | $2,236,000 | +45.0% | 35,000 | 0.0% | 0.74% | +5.7% | |
| ASND | Ascendis Pharma ASsponsored adr | $1,999,000 | +29.1% | 13,800 | 0.0% | 0.66% | -5.9% | |
| XLRN | ACCELERON PHARMA INC | $1,729,000 | +6.9% | 18,000 | 0.0% | 0.58% | -22.0% | |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $1,651,000 | +77.5% | 22,000 | 0.0% | 0.55% | +29.5% | |
| SAGE | Sage Therapeutics Inc | $1,570,000 | +45.8% | 37,600 | 0.0% | 0.52% | +6.3% | |
| IMUX | New | IMMUNIC INC | $1,531,000 | – | 123,000 | +100.0% | 0.51% | – |
| NKTR | NEKTAR THERAPEUTICS | $1,499,000 | +25.6% | 67,000 | 0.0% | 0.50% | -8.5% | |
| FOLD | Amicus Therapeutics Inc | $1,470,000 | +68.4% | 94,600 | 0.0% | 0.49% | +22.9% | |
| PRNB | PRINCIPIA BIOPHARMA INC | $1,298,000 | -3.9% | 23,100 | 0.0% | 0.43% | -30.0% | |
| QURE | UNIQURE NV | $1,257,000 | -2.5% | 27,500 | 0.0% | 0.42% | -28.9% | |
| GWPH | GW Pharmaceuticals Plcads | $1,244,000 | +39.3% | 10,200 | 0.0% | 0.41% | +1.7% | |
| ALLK | ALLAKOS INC | $1,143,000 | +65.2% | 15,700 | 0.0% | 0.38% | +20.6% | |
| AGIO | Agios Pharmaceuticals Inc | $1,139,000 | +49.5% | 21,500 | 0.0% | 0.38% | +9.2% | |
| STRO | SUTRO BIOPHARMA INC | $1,097,000 | -20.2% | 139,331 | 0.0% | 0.36% | -41.8% | |
| ARNA | Arena Pharmaceuticals Inc | $1,037,000 | +50.3% | 16,500 | 0.0% | 0.34% | +9.5% | |
| DCPH | DECIPHERA PHARMACEUTICALS INC | $994,000 | +42.6% | 17,000 | 0.0% | 0.33% | +3.8% | |
| MNTA | MOMENTA PHARMACEUTICALS INC | $970,000 | +32.2% | 27,000 | 0.0% | 0.32% | -3.9% | |
| EXAS | Exact Sciences Corp | $920,000 | +48.6% | 10,700 | 0.0% | 0.31% | +8.5% | |
| BPMC | Blueprint Medicines Corp | $918,000 | +31.1% | 12,000 | 0.0% | 0.30% | -4.4% | |
| INSM | INSMED INC | $902,000 | +68.0% | 33,600 | 0.0% | 0.30% | +22.4% | |
| FGEN | FibroGen Inc | $799,000 | +16.8% | 19,700 | 0.0% | 0.27% | -14.7% | |
| BLUE | Bluebird Bio Inc | $660,000 | +30.7% | 11,000 | 0.0% | 0.22% | -4.8% | |
| GBT | Global Blood Therapeutics | $652,000 | +30.9% | 9,800 | 0.0% | 0.22% | -4.4% | |
| ITCI | INTRA CELLULAR THERAPIES INC | $579,000 | +64.5% | 23,000 | 0.0% | 0.19% | +20.0% | |
| ESPR | ESPERION THERAPEUTICS INC NE | $452,000 | +51.7% | 9,500 | 0.0% | 0.15% | +10.3% | |
| ANAB | ANAPTYSBIO INC | $227,000 | +62.1% | 10,000 | 0.0% | 0.08% | +17.2% | |
| ZEAL | ZEALAND PHARMA A Ssponsored adr | $187,000 | +2.2% | 5,653 | 0.0% | 0.06% | -25.3% | |
| TCDA | Exit | Tricida Inc | $0 | – | -29,000 | -100.0% | -0.29% | – |
| ALKS | Exit | ALKERMES PLC | $0 | – | -52,000 | -100.0% | -0.34% | – |
| MLND | Exit | Millendo Therapeutics Inc | $0 | – | -177,825 | -100.0% | -0.43% | – |
| AMRN | Exit | Amarin Corp Plcspons adr new | $0 | – | -320,000 | -100.0% | -0.58% | – |
| LLY | Exit | LILLY ELI & CO | $0 | – | -20,000 | -100.0% | -1.26% | – |
| MRK | Exit | MERCK & CO INC | $0 | – | -83,200 | -100.0% | -2.92% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-07-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
| INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
| BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
| REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
| BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
| VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
| AMGEN INC COM | 25 | Q3 2023 | 7.9% |
| NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
| ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
| IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
| MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
| EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
| ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
| TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
| ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
| ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
| CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
| RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-18 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-20 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.